Progestin Intrauterine Device in an Adolescent With Grade 2 Endometrial Cancer

被引：36
作者：
Brown, Alaina J.
Westin, Shannon N.
Broaddus, Russell R.
Schmeler, Kathleen [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77230 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2012年 / 119卷 / 02期
关键词：
WOMEN; 40; YEARS; YOUNG-WOMEN; ADENOCARCINOMA;
D O I：
10.1097/AOG.0b013e318234d97c
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
BACKGROUND: The treatment of endometrial cancer in young women who desire future fertility poses several challenges. Oral progestin and progestin-releasing intrauterine devices (IUDs) have been shown to result in regression of endometrial hyperplasia and grade 1 endometrioid endometrial carcinoma. However, limited data are available on the use of these methods in women with grade 2 disease. CASE: An 18-year-old nulliparous woman was diagnosed with a grade 2 endometrial adenocarcinoma. She desired future fertility and therefore underwent placement of a levonorgestrel-releasing IUD. The patient subsequently underwent endometrial sampling every 3 months and remained disease-free 13 months after initial IUD placement. CONCLUSION: A progestin-releasing IUD may be a valid treatment option for grade 2 endometrial cancer in young women who desire to retain fertility. (Obstet Gynecol 2012;119:423-6) DOI:10.1097/AOG.0b013e318234d97c
引用
收藏
页码：423 / 426
页数：4
相关论文
共 11 条
[1]   Sparing fertility in young patients with endometrial cancer [J].
Chiva, Luis ;
Lapuente, Fernando ;
Gonzalez-Cortijo, Lucia ;
Carballo, Natalia ;
Garcia, Juan F. ;
Rojo, Alejandro ;
Gonzalez-Martin, Antonio .
GYNECOLOGIC ONCOLOGY, 2008, 111 (02) :S101-S104
[2]   Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature [J].
Dhar, KK ;
NeedhiRajan, T ;
Koslowski, A ;
Woolas, RP .
GYNECOLOGIC ONCOLOGY, 2005, 97 (03) :924-927
[3]   Endometrial cancer in women 40 years old or younger [J].
Duska, LR ;
Garrett, A ;
Rueda, BR ;
Haas, J ;
Chang, YC ;
Fuller, AF .
GYNECOLOGIC ONCOLOGY, 2001, 83 (02) :388-393
[4]   Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis [J].
Gallos, Ioannis D. ;
Shehmar, Manjeet ;
Thangaratinam, Shakila ;
Papapostolou, Thalis K. ;
Coomarasamy, Arri ;
Gupta, Janesh K. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (06) :547.e1-547.e10
[5]  
GALLUP DG, 1984, OBSTET GYNECOL, V64, P417
[6]   Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma [J].
Jadoul, P ;
Donnez, J .
FERTILITY AND STERILITY, 2003, 80 (06) :1315-1324
[7]   Intrauterine progesterone treatment of early endometrial cancer [J].
Montz, FJ ;
Bristow, RE ;
Bovicelli, A ;
Tomacruz, R ;
Kurman, RJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) :651-657
[8]   Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger [J].
Ota, T ;
Yoshida, M ;
Kimura, M ;
Kinoshita, K .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (04) :657-662
[9]   Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review [J].
Ramirez, PT ;
Frumovitz, M ;
Bodurka, DC ;
Sun, CC ;
Levenback, C .
GYNECOLOGIC ONCOLOGY, 2004, 95 (01) :133-138
[10]   Endometrial Cancer in an Adolescent A Possible Manifestation of Cowden Syndrome [J].
Schmeler, Kathleen M. ;
Daniels, Molly S. ;
Brandt, Amanda C. ;
Lu, Karen H. .
OBSTETRICS AND GYNECOLOGY, 2009, 114 (02) :477-479
12